Evidence map›Paper›PMID 32945111›Full record

ArticleJournal of thrombosis and haemostasis : JTH2020

Defibrotide in the COVID-19 coagulopathy: What is the timing?

Antonio Macciò, Clelia Madeddu, Giovanni Caocci, Sara Oppi, Giorgio La Nasa

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Antonio MacciòDepartment of Gynecologic Oncology, Businco Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Clelia MadedduDepartment of Medical Sciences and Public Health, Medical Oncology Unit, University of Cagliari, Cagliari, Italy.
Giovanni CaocciDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Sara OppiHematology and Transplant Center, Businco Hospital, Azienda Ospedaliera Brotzu, Cagliari, Italy.
Giorgio La NasaDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
University of Cagliari · ITAzienda Ospedaliera G. Brotzu · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood Coagulation DisordersCOVID-19Fibrinolytic AgentsHumansPandemicsPolydeoxyribonucleotidesSARS-CoV-2defibrotideFibrinolytic AgentsPolydeoxyribonucleotidescoagulopathyCOVID-19defibrotideresistancetolerance

Identifiers

PMID32945111
PMCPMC7537223
OpenAlexW3087367857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.